Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting ligands for tau pathology

Targeting ligands for tau pathology

US Patent 12298318 · Granted May 13, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual mode gadolinium nanoparticle contrast agents2024
Targeted contrast agents for MRI of alpha-synuclein deposition2023
Targeting ligands for tau pathology2023
Targeting nanoparticles2022
Hydrophilic fluorinated molecules for liposomal 19F MRI probes with unique MR si2022
MRI imaging of amyloid plaque using liposomes2021
Targeted contrast agents for MRI of amyloid deposition2021
Liposomal gadolinium (GD) contrast agent “NMRX” for T1-MRI2021
MRI imaging of amyloid plaque using liposomes2020
Methods and compositions for objectively characterizing medical images2018
Lipid-based nanoparticles2018
Lipid-based nanoparticles2017